News Sentiment

AVE sentiment intelligence

Avecho Biotechnology Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 50 Balanced news tone 28 relevant articles

Exchange ASX Australia

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 0.02 Week of 19 Jun 2026

Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

77/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+36.4% over one week, +15.4% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?

Market Reaction

Price moving ahead of tone

57/100 confidence

Primary event Earnings 77/100 classification

One-week reaction 36.4% Price confirming higher

Trend fit Trend active 15.4% over four weeks

Fair value 174.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 4

Neutral 19

Negative 5

Relevance

Why the article matched

Direct first

Direct company coverage 28

Industry context 0

Sector context 0

Sources

Coverage mix

Publishers

Market source 7

simplywall.st 5

TradingView 3

smallcaps.com.au 2

Stocktwits 1

Finance News Network 1

Investing.com 1

marketscreener.com 1

Event Lens

What the news is about

Classified themes

Earnings 14

Market update 12

Deals and strategy 2

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-28 of 28

Stocktwits Direct company coverage

Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?

Tone: Positive 66/100
Event: Market update
Published: 19 Jun 2026 17:14
Source: Stocktwits

Finance News Network Direct company coverage

Daily Special: Brightstar Resources, Constellation Resources, Avecho Biotechnology, Magmatic Resources

Tone: Neutral 50/100
Event: Market update
Published: 21 May 2026 07:00
Source: Finance News Network

simplywall.st Direct company coverage

There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings

Tone: Negative 34/100
Event: Earnings
Published: 15 May 2026 07:00
Source: simplywall.st

Market source Direct company coverage

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Tone: Neutral 50/100
Event: Earnings
Published: 14 May 2026 07:00
Source: Market source

Investing.com Direct company coverage

Earnings call transcript: PDS Biotechnology beats Q1 2026 EPS expectations

Tone: Positive 66/100
Event: Earnings
Published: 13 May 2026 07:00
Source: Investing.com

TradingView Direct company coverage

PDS Biotechnology Q1 Earnings Call Highlights

Tone: Neutral 50/100
Event: Earnings
Published: 13 May 2026 07:00
Source: TradingView

simplywall.st Direct company coverage

Is Sana Biotechnology’s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?

Tone: Neutral 50/100
Event: Earnings
Published: 11 May 2026 07:00
Source: simplywall.st

Market source Direct company coverage

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Tone: Neutral 50/100
Event: Earnings
Published: 11 May 2026 07:00
Source: Market source

marketscreener.com Direct company coverage

Earnings Flash (SANA) Sana Biotechnology, Inc. Posts Q1 Adjusted Loss $0.14 per Share, vs. FactSet Est of $-0.16

Tone: Negative 34/100
Event: Earnings
Published: 11 May 2026 07:00
Source: marketscreener.com

simplywall.st Direct company coverage

Vir Biotechnology, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Tone: Negative 34/100
Event: Market update
Published: 11 May 2026 07:00
Source: simplywall.st

Kalkine Media Direct company coverage

Is Avecho Biotechnology (ASX:AVE) the Next ASX 300 Healthcare Stock in Focus?

Tone: Neutral 50/100
Event: Market update
Published: 07 May 2026 07:00
Source: Kalkine Media

Market source Direct company coverage

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Tone: Neutral 50/100
Event: Earnings
Published: 25 Apr 2026 07:00
Source: Market source

Market source Direct company coverage

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)

Tone: Neutral 50/100
Event: Earnings
Published: 21 Apr 2026 07:00
Source: Market source

Market source Direct company coverage

A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack

Tone: Neutral 50/100
Event: Earnings
Published: 30 Mar 2026 07:00
Source: Market source

Market source Direct company coverage

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Tone: Negative 34/100
Event: Market update
Published: 18 Mar 2026 07:00
Source: Market source

Kavout Direct company coverage

Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates

Tone: Neutral 50/100
Event: Market update
Published: 28 Feb 2026 09:53
Source: Kavout

TIKR.com Direct company coverage

Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results

Tone: Positive 66/100
Event: Earnings
Published: 25 Feb 2026 08:00
Source: TIKR.com

Barron's Direct company coverage

These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More

Tone: Neutral 50/100
Event: Market update
Published: 24 Feb 2026 08:00
Source: Barron's

Market source Direct company coverage

Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates

Tone: Neutral 50/100
Event: Earnings
Published: 23 Feb 2026 08:00
Source: Market source

simplywall.st Direct company coverage

With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case

Tone: Positive 66/100
Event: Earnings
Published: 09 Dec 2025 08:00
Source: simplywall.st

smallcaps.com.au Direct company coverage

Avecho Biotechnology Receives US and EU Patent Allowances for Proprietary CBD Soft-Gel Capsule

Tone: Neutral 50/100
Event: Market update
Published: 02 Dec 2025 08:00
Source: smallcaps.com.au

simplywall.st Direct company coverage

Avecho Biotechnology First Half 2025 Earnings: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2024)

Tone: Negative 18/100
Event: Earnings
Published: 31 Aug 2025 07:00
Source: simplywall.st

Biotech Dispatch Direct company coverage

Avecho Biotechnology secures ten-year agreement with Sandoz

Tone: Neutral 50/100
Event: Market update
Published: 04 Mar 2025 08:00
Source: Biotech Dispatch

Capital Brief Direct company coverage

Small-cap ASX biotech Avecho strikes Sandoz deal for CBD insomnia treatment

Tone: Neutral 50/100
Event: Deals and strategy
Published: 03 Mar 2025 08:00
Source: Capital Brief

smallcaps.com.au Direct company coverage

Avecho Biotechnology signs exclusive licensing deal with Sandoz for CBD insomnia treatment

Tone: Neutral 50/100
Event: Deals and strategy
Published: 03 Mar 2025 08:00
Source: smallcaps.com.au

TradingView Direct company coverage

AVE Stock Price and Chart — ASX:AVE

Tone: Neutral 50/100
Event: Market update
Published: 08 Jul 2021 07:00
Source: TradingView

intelligentinvestor.com.au Direct company coverage

Avecho Biotechnology Limited (ASX:AVE)

Tone: Neutral 50/100
Event: Market update
Published: 27 Sep 2019 03:45
Source: intelligentinvestor.com.au

TradingView Direct company coverage

Technical Analysis of Avecho Biotechnology Limited (ASX:AVE)

Tone: Neutral 50/100
Event: Market update
Published: 09 Jun 2019 03:41
Source: TradingView